{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T19:51:54Z","timestamp":1718308314495},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.0254","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T16:36:07Z","timestamp":1646066167000},"page":"e220254","source":"Crossref","is-referenced-by-count":4,"title":["Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node\u2013Positive and High-Risk Lymph Node\u2013Negative Breast Cancer"],"prefix":"10.1001","volume":"5","author":[{"given":"Shoshana M.","family":"Rosenberg","sequence":"first","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"},{"name":"ECOG-ACRIN Biostatistics Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Sepucha","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy D.","family":"Miller","sequence":"additional","affiliation":[{"name":"Indiana University, Indianapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chau T.","family":"Dang","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald W.","family":"Northfelt","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George W.","family":"Sledge","sequence":"additional","affiliation":[{"name":"Indiana University, Indianapolis"},{"name":"Stanford University, Stanford, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan P.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Indiana University, Indianapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"issue":"9","key":"zoi220021r1","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1200\/JCO.2010.28.8043","article-title":"Physical and psychosocial recovery in the year after primary treatment of breast cancer.","volume":"29","author":"Ganz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi220021r2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/BF02951424","article-title":"Impact on quality of life of adjuvant therapy for breast cancer.","volume":"9","author":"Moore","year":"2007","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"zoi220021r3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11136-020-02652-w","article-title":"Patient-reported outcomes in survivors of breast cancer one, three, and five years post-diagnosis: a cancer registry-based feasibility study.","volume":"30","author":"Skandarajah","year":"2021","journal-title":"Qual Life Res"},{"issue":"25","key":"zoi220021r4","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1200\/JCO.2018.79.2028","article-title":"Double-blind phase III trial of adjuvant chemotherapy with and without bevacizumab in patients with lymph node-positive and high-risk lymph node-negative breast cancer (E5103).","volume":"36","author":"Miller","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi220021r5","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1200\/JCO.1997.15.3.974","article-title":"Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.","volume":"15","author":"Brady","year":"1997","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi220021r6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"issue":"9","key":"zoi220021r7","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jclinepi.2004.01.012","article-title":"A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale.","volume":"57","author":"Eton","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"zoi220021r8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/PROM.S10621","article-title":"Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire.","volume":"1","author":"King","year":"2010","journal-title":"Patient Relat Outcome Meas"},{"issue":"5","key":"zoi220021r9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group.","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"zoi220021r10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1477-7525-5-70","article-title":"Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer.","volume":"5","author":"Pickard","year":"2007","journal-title":"Health Qual Life Outcomes"},{"issue":"157","key":"zoi220021r11","first-page":"445","article-title":"A sociodemographic data collection model for cooperative clinical trials.","volume":"11","author":"Holland","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"2","key":"zoi220021r12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/0163278705275341","article-title":"General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G).","volume":"28","author":"Brucker","year":"2005","journal-title":"Eval Health Prof"},{"issue":"6","key":"zoi220021r13","article-title":"Risk stratification for the development of chronic postsurgical pain.","volume":"2","author":"Schug","year":"2017","journal-title":"Pain Rep"},{"issue":"1","key":"zoi220021r14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40265-019-01227-5","article-title":"Treating persistent pain after breast cancer surgery.","volume":"80","author":"Khan","year":"2020","journal-title":"Drugs"},{"issue":"14","key":"zoi220021r15","doi-asserted-by":"publisher","first-page":"E352","DOI":"10.1503\/cmaj.151276","article-title":"Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies.","volume":"188","author":"Wang","year":"2016","journal-title":"CMAJ"},{"issue":"12","key":"zoi220021r16","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1007\/s00520-017-3824-3","article-title":"Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis.","volume":"25","author":"Leysen","year":"2017","journal-title":"Support Care Cancer"},{"issue":"3","key":"zoi220021r17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10549-016-3965-y","article-title":"Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors.","volume":"159","author":"Pinheiro","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"zoi220021r18","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1002\/cncr.v113:11","article-title":"Breast cancer survivors\u2019 health-related quality of life: racial differences and comparisons with noncancer controls.","volume":"113","author":"Paskett","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"zoi220021r19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10549-006-9479-2","article-title":"Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors.","volume":"106","author":"Bowen","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"zoi220021r20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamasurg.2014.23","article-title":"Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.","volume":"149","author":"Black","year":"2014","journal-title":"JAMA Surg"},{"issue":"2","key":"zoi220021r21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/cncr.v127.2","article-title":"Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): a lymphedema prevention intervention trial for newly diagnosed breast cancer patients.","volume":"127","author":"Naughton","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"zoi220021r22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11764-012-0247-5","article-title":"Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes.","volume":"7","author":"Pusic","year":"2013","journal-title":"J Cancer Surviv"},{"issue":"6","key":"zoi220021r23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology breast cancer survivorship care guideline.","volume":"34","author":"Runowicz","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2789450\/rosenberg_2022_oi_220021_1645202365.53156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T16:36:15Z","timestamp":1646066175000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2789450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.0254","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]}}}